Frontiers in Oncology

Original Research

Published on 17 Aug 2023

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1

in Skin Cancer

Eszter Anna Janka
Beatrix Ványai
Imre Lőrinc Szabó
Tünde Toka-Farkas
Tünde Várvölgyi
Anikó Kapitány
Andrea Szegedi
Gabriella Emri

Frontiers in Oncology

doi 10.3389/fonc.2023.1237643

1,842 views
5 citations

Original Research

Published on 17 Aug 2023

Causal association between serum 25-Hydroxyvitamin D levels and cutaneous melanoma: a two-sample Mendelian randomization study

in Skin Cancer

Beichen Cai
Qian Lin
Ruonan Ke
Xiuying Shan
Jiaqi Yu
Xuejun Ni
Xinjian Lin
Biao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1154107

4,148 views
8 citations

Editorial

Published on 08 Aug 2023

Editorial: Women in skin cancer vol II: 2022

in Skin Cancer

Selma Ugurel
Sapna P. Patel

Frontiers in Oncology

doi 10.3389/fonc.2023.1253081

1,354 views

Case Report

Published on 01 Aug 2023

Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-β and PD-L1

in Skin Cancer

Rongbin Qi
Hailing Xu
Xinyu Fu
Yingying Yu
Dongqing Lv
Yujing Li
Susu He

Frontiers in Oncology

doi 10.3389/fonc.2023.1046266

2,014 views
3 citations

Original Research

Published on 13 Jul 2023

A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged >50 with advanced melanoma

in Skin Cancer

Qiufen Xi
Xiaoou Lu
Jiali Zhang
Da Wang
Yu Sun
Hongquan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1166877

2,119 views

Original Research

Published on 13 Jul 2023

Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma

in Skin Cancer

Wei Zheng
Wei Ju
Xi-Hu Yang
Zhi-Xin Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1113604

2,022 views
1 citation

Case Report

Published on 05 Jul 2023

Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases

in Skin Cancer

Joshua Rusheen
James Clune
Stephan Ariyan
Raymond Baumann
Harriet Kluger
Kelly Olino
Sarah Weiss

Frontiers in Oncology

doi 10.3389/fonc.2023.1217816

1,950 views
3 citations

Original Research

Published on 23 Jun 2023

Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022

in Skin Cancer

Yantong Wan
Junyi Shen
Yinghao Hong
Jinghua Liu
Tieliu Shi
Junwei Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1181164

5,159 views
12 citations

Review

Published on 19 Jun 2023

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations

in Skin Cancer

Lucía Vázquez-Montero
María del Carmen Álamo de la Gala
Luis de la Cruz-Merino

Frontiers in Oncology

doi 10.3389/fonc.2023.1187840

12,157 views
2 citations

Original Research

Published on 19 Jun 2023

Bioinformatic-based genetic characterizations of neural regulation in skin cutaneous melanoma

in Skin Cancer

Fengdi Wang
Fanjun Cheng
Fang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1166373

3,059 views
4 citations

Original Research

Published on 16 Jun 2023

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study

in Skin Cancer

Ryan C. Augustin
Ziyu Huang
Fei Ding
Shuyan Zhai
Jennifer McArdle
Anthony Santisi
Michael Davis
Cindy Sander
Diwakar Davar
John M. Kirkwood

Frontiers in Oncology

doi 10.3389/fonc.2023.1075823

3,895 views
13 citations

Original Research

Published on 14 Jun 2023

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma

in Skin Cancer

TengFei Deng
Chaoyong Wang
Cong Gao
Qiang Zhang
Jun Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1181537

2,588 views
4 citations

Original Research

Published on 09 Jun 2023

A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma

in Skin Cancer

Sebastian Bauer
James Larkin
F. Stephen Hodi
Frank Stephen
Ellen H. W. Kapiteijn
Gary K. Schwartz
Emilano Calvo
Padmaja Yerramilli-Rao
Sophie Piperno-Neumann
Richard D. Carvajal

Frontiers in Oncology

doi 10.3389/fonc.2022.975642

4,395 views
7 citations

Original Research

Published on 19 May 2023

Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary

in Skin Cancer

Veronika Tóth
Stefani Christina Diakoumakou
Enikő Kuroli
Béla Tóth
Daniella Kuzmanovszki
József Szakonyi
Kende Kálmán Lőrincz
Beáta Somlai
Sarolta Kárpáti
Péter Holló

Frontiers in Oncology

doi 10.3389/fonc.2023.1142170

2,358 views
1 citation

Correction

Published on 18 May 2023

Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sections

in Skin Cancer

Katharina Kriegsmann
Frithjof Lobers
Christiane Zgorzelski
Jörg Kriegsmann
Charlotte Janßen
Rolf Rüdinger Meliß
Thomas Muley
Ulrich Sack
Georg Steinbuss
Mark Kriegsmann

Frontiers in Oncology

doi 10.3389/fonc.2023.1201237

1,256 views
2 citations

Original Research

Published on 18 May 2023

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma

in Skin Cancer

Ronen Stoff
Nethanel Asher
Shachar Laks
Yael Steinberg
Jacob Schachter
Ronnie Shapira-Frommer
Shirly Grynberg
Guy Ben-Betzalel

Frontiers in Oncology

doi 10.3389/fonc.2023.1180988

4,028 views
13 citations